Sit Investment Associates’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Sit Investment Associates's ATRC Position: Q2 2026 in Review
Sit Investment Associates held its AtriCure (ATRC) position steady in Q2 2026 at 113,330 shares worth $3.17M. The position accounts for 0.06% of the portfolio, ranked #253.
Sit Investment Associates first reported a position in ATRC in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.27M in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Sit Investment Associates held 113,330 shares of AtriCure worth $3.17M as of Q2 2026.
- Sit Investment Associates left its AtriCure share count unchanged in Q2 2026.
- AtriCure made up 0.06% of Sit Investment Associates's portfolio in Q2 2026, its #253 holding.
- Sit Investment Associates first reported a position in AtriCure in Q4 2019 and has held it in 27 quarters since.
- Sit Investment Associates's AtriCure position peaked at $4.27M in Q4 2025.
- 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.